Redplate has a new gig.
TapImmune Appoints Mark Reddish to Its Management Team as Vice President Product Development
Former Executive at ID Biomedical and Biomira Inc Brings Broad Experience and Expertise in Cancer and Biodefense Product Development
Mark was far to young and mentally active to retire to the golf course.
It is interesting that his work should be in the field that he was challenged by two posters here.
Such is life.
>>It is interesting that his work should be in the field that he was challenged by two posters here.<<
Has someone been challenging Redplate’s work in product development?
Redplate has earned my grief because of his constant lying that makes this investment look rosier than is deserved and his antiquated understanding of T cell assays. Remember his story that the 20% positive immune response in the phase II trial shouldn’t be believed because when the same exact assays were performed immediately during a phase I study the response was 13/17? Then we found out the 17 patients were healthy normals and the therapy was given ex-vivo. What a dunce. And when arguing against IFN-gamma ELISPOT we got, “killer cells kill.” What a simpleton.
So no walshingham07, working for another podunk btech isn’t going to impress me. Just as little can be made from GSK not wanting him around and his not earning a PhD.
Hope the Red Head packs a sustaining lunch box.
Hope the new office has an after lunch thinking couch for contemplation in the horizontal position.
Pick an ugly secretary you do not want your hide nailed to the barn door by the Red Head.
Zanghia - great buy on VRUS. I looked at it at $12/sh (unsplit) after your recommendation, but just watched it go up. Thought about getting a 1000 shares, but nooooo. Too caught up in ONTY - intellectually and $$$ wise. These bios are hard for me to keep up with the jargon. Trying to understand two at once just would be too much for me. Anyway, do you really thing ONTY "will go no place"?? Trails been running awhile now. I would like to know why you don't think this is going places? Are we just drinking the Kool Aid?
Hey zanghia, congrats on VRUS.
Not sure why you'd need to conclude that ONTY was a dud, though.
Feels like your timing is splendiferous.
Why wouldn't you want to double up now? This thing is on a short fuse!
That’s cool. I think I’ve made a pretty good argument that the 20% positive T cell response can’t be ignored because of the delay caused by shipping. I also think my discussion on what constitutes a truly robust T cell response (sustained longer than a single time point) was strong. It isn’t my fault if you chose hype over empiricism.
Looking at Martin's biography, besides being a self proclaimed philanthropist, he appears to have completed High School or at least got a GED. There is no statement of obtaining a college degree from my recollection,just an "he attended" mention.I think he is busy with his buyout efforts and keeping his well educated daughter in line.She may be "going native" here. Getting beaten down. Maybe a case of the Stockholm Syndrome.